Skip to content

Comparison of Oral & Intramuscular injection form of Vitamin D in patients with vitamin D deficiency

Comparison of Oral & Intramuscular injection form of Vitamin D prescription on the Serum 25-Hydroxy-vitamin D level in patients with vitamin D deficiency

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191030045277N1
Enrollment
300
Registered
2020-06-23
Start date
2019-12-29
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency. Vitamin D deficiency

Interventions

Intervention 1: Intervention group 1: For patients in this group, the pearl of vitamin D (D-vitin, the product of Zahravi`s company) 50000 U weekly until eight weeks is prescribed, and serum level of

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Every body older than 18 years Serum 25(OH)D3 level lower than 20 ng/mL

Exclusion criteria

Exclusion criteria: Patient dissatisfaction Known gastrointestinal disease effective on vitamin D absorption Low serum albumin level Chronic Renal Failure Hepatic failure Taking medication effective on vitamin D & calcium metabolism Pregnancy Malignancy Untreated thyroid disorder Primary hyperparathyroidism

Design outcomes

Primary

MeasureTime frame
Serum level of vitamin D. Timepoint: Measurement of serum level of vitamin D at the beginning of study & the end of eighth week. Method of measurement: Based on measurement of serum level of vitamin D in laboratory.

Secondary

MeasureTime frame
Serum level of vitamin D. Timepoint: Measurement of serum level of vitamin D at the beginning of study & the end of eighth week. Method of measurement: Based on measurement of serum level of vitamin D in laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadali Bayani

Babol University of Medical Sciences

bayanima49@yahoo.com+98 11 3223 8309

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026